Fundz

Dark Genome Biotech HERVolution Therapeutics raised $11.7M in a Series A round to advance treatments for cancer and diseases of aging.

PRIVATEDec 19, 2024

Amount Raised

$11.7 Million

Round Type

Series A

CopenhagenBiotechnology

Investors

European Innovation Council Fund

Description

Dark Genome Biotech HERVolution Therapeutics has successfully secured $11.7 million in a Series A financing round. The funds will be utilized to further their research and development of innovative treatments targeting cancer and aging-related diseases.

Quick answer

Hervolution Therapeutics raised $11.7 Million in a Series A round, dated December 19, 2024. Investors: European Innovation Council Fund. Hervolution Therapeutics is based in Copenhagen, Capital Region Of Denmark, Denmark.

How much did Hervolution Therapeutics raise?
Hervolution Therapeutics raised $11.7 Million in a Series A round on December 19, 2024.
Who invested in Hervolution Therapeutics?
European Innovation Council Fund is named as investors in this round.
What does Hervolution Therapeutics do?
HERVolution Therapeutics (formerly InProTher Aps) is a dark genome-focused biotechnology company based in Copenhagen, Denmark, and the U.S., pioneering novel human endogenous retrovirus (HERV)-targeted immunotherapies..
Where is Hervolution Therapeutics based and how big is it?
Hervolution Therapeutics is based in Copenhagen, Capital Region Of Denmark, Denmark.
Who are the decision-makers at Hervolution Therapeutics?
Fundz holds 1 contact at Hervolution Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Hervolution Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Tensive raised $15M (Series A) on February 1, 2025.
  • Commit Biologics raised $5.7M (Seed) on February 1, 2025.
  • Kemin Industries raised $20M on January 31, 2025.
  • C the Signs raised $8M (Funding Round) on January 31, 2025.
  • BioPoly raised $1.1M on January 31, 2025.
  • Phlow raised $31M on January 31, 2025.

Who to call at Hervolution Therapeutics, and when

A new round usually means Hervolution Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Hervolution Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hervolution Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hervolution Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Hervolution Therapeutics

Location

Copenhagen, Capital Region Of Denmark, Denmark

About

HERVolution Therapeutics (formerly InProTher Aps) is a dark genome-focused biotechnology company based in Copenhagen, Denmark, and the U.S., pioneering novel human endogenous retrovirus (HERV)-targeted immunotherapies to address diseases of aging. With its proprietary engineering approaches, HERVolution has rationally redesigned HERV-antigens to yield a new class of highly immunogenic antigens to address cancer, metabolic, and other aging-related diseases. The company's world-class scientific team has advanced a strong product development pipeline, with lead program, IPT-001, anticipated to enter the clinic in 2025.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Hervolution Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Hervolution Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Hervolution Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.